To hear about similar clinical trials, please enter your email below
Trial Title:
Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient
NCT ID:
NCT05628246
Condition:
Pain, Chronic
Cancer Pain
Conditions: Official terms:
Cancer Pain
Chronic Pain
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Health Services Research
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
Telemedicine
Description:
Telemedicine
Arm group label:
Telemedicine
Intervention type:
Other
Intervention name:
In-person
Description:
In-person
Arm group label:
In-person
Summary:
Cancer is the second leading cause of death worldwide, with approximately 18.1 million
new cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by
50-70% of patients, with a higher prevalence at advanced disease stages (66.4%). Since
the development of WHO's cancer pain guidelines, several studies have reported good
relief of symptoms and suffering for a majority of patients. Recent reports suggest that
up to 50% of patients still report insufficient pain control. Patients with cancer often
present with multiple symptoms and functional decline. Evidence supports
multidisciplinary approaches to address symptoms and suffering, including early
palliative care referral
From review literatures we found that the telemedicine group had significantly higher
quality of life than the usual care group. In addition, the telemedicine group had lower
anxiety and depression scores than the usual care group.
Therefore, we will conduct the non-randomized controlled study of using telemedicine
comparing to conventional in-person at OPD in hospitalized cancer pain patients.
The purpose of this study is to assess the pain interference by using the Brief Pain
Inventory (BPI) and to compare between the in-person group and the telemedicine group. To
assess the cost-effectiveness of telemedicine for reducing symptoms associated with
cancer and its treatment.
Detailed description:
The pain interference will be assessed and compared using Brief Pain Inventory from 0-70
between In-person group and telemedicine group at 1 month.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age older than 18 years old
- Cancer patients who new visit as out patient at pain clinic, Siriraj hospital
Exclusion Criteria:
- Cannot read and write
- Confusion
- Unable to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity.
- Unstable clinical presentation
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Faculty of medicine Siriraj Hospital Mahidol University
Address:
City:
Bangkoknoi
Zip:
10700
Country:
Thailand
Status:
Recruiting
Contact:
Last name:
Suratsawadee Wangnamthip, M.D.
Phone:
+66-81-926-1509
Email:
suratsawadee.wan@mahidol.ac.th
Investigator:
Last name:
Suratsawadee Wangnamthip, M.D.
Email:
Principal Investigator
Start date:
January 19, 2023
Completion date:
July 17, 2025
Lead sponsor:
Agency:
Mahidol University
Agency class:
Other
Source:
Mahidol University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05628246
